Subtopic Deep Dive
Dihydromyricetin Hepatoprotective Mechanisms
Research Guide
What is Dihydromyricetin Hepatoprotective Mechanisms?
Dihydromyricetin hepatoprotective mechanisms refer to the molecular pathways by which dihydromyricetin, a flavonoid from Ampelopsis grossedentata, protects liver cells against alcohol-induced injury, oxidative stress, and lipid peroxidation primarily via Nrf2 activation and ROS reduction.
Studies demonstrate dihydromyricetin's role in alleviating carbon tetrachloride-induced acute liver injury through JNK-dependent mechanisms (Xie, 2015, 86 citations). It reduces reactive oxygen species to induce apoptosis in hepatocellular carcinoma cells (Liu et al., 2014, 89 citations). Animal models and hepatocyte assays reveal its protection against alcohol intoxication and liver damage (Shen et al., 2012, 209 citations). Over 20 papers explore these effects since 2012.
Why It Matters
Dihydromyricetin's ability to counter alcohol-induced liver injury positions it as a potential adjunct therapy for alcoholic liver disease, as shown in mouse models where it mitigates intoxication via GABA_A receptor modulation (Shen et al., 2012). Its ROS reduction protects against hepatocellular carcinoma progression (Liu et al., 2014) and carbon tetrachloride toxicity (Xie, 2015), offering applications in metabolic disorders and drug-induced hepatotoxicity. In diabetic cardiomyopathy models, it improves cardiac outcomes linked to liver health (Wu et al., 2017). These mechanisms support its use in preventing oxidative stress-related liver pathologies.
Key Research Challenges
Elucidating Nrf2 Pathway Specificity
Distinguishing dihydromyricetin's Nrf2 activation from off-target effects in alcohol models remains unclear. Studies like Xie (2015) show JNK involvement but lack isoform-specific data. Hepatocyte assays need advanced knockout models for validation.
Translating Animal Model Findings
Mouse and rat studies (Shen et al., 2012; Xie, 2015) demonstrate protection, but human pharmacokinetics data is absent. Dose-response inconsistencies across species hinder clinical trials. Biomarker identification for liver injury reversal is needed.
Quantifying ROS Reduction Mechanisms
Liu et al. (2014) link ROS decline to apoptosis, yet paradoxical cancer promotion risks exist. Metabolomics integration (Le et al., 2016) reveals insulin sensitivity gains but not direct hepatoprotective flux. Pathway crosstalk with inflammation requires dissection.
Essential Papers
Role of Antioxidants and Natural Products in Inflammation
Palanisamy Arulselvan, Masoumeh Tangestani Fard, Woan Sean Tan et al. · 2016 · Oxidative Medicine and Cellular Longevity · 949 citations
Inflammation is a comprehensive array of physiological response to a foreign organism, including human pathogens, dust particles, and viruses. Inflammations are mainly divided into acute and chroni...
Dihydromyricetin As a Novel Anti-Alcohol Intoxication Medication
Yi Shen, A. Kerstin Lindemeyer, Claudia L. R. Gonzalez et al. · 2012 · Journal of Neuroscience · 209 citations
Alcohol use disorders (AUDs) constitute the most common form of substance abuse. The development of AUDs involves repeated alcohol use leading to tolerance, alcohol withdrawal syndrome, and physica...
Alcohol use disorders and current pharmacological therapies: the role of GABAA receptors
Jing Liang, Richard W. Olsen · 2014 · Acta Pharmacologica Sinica · 152 citations
The Versatile Effects of Dihydromyricetin in Health
LI Hong-liang, Qisheng Li, Zhaowen Liu et al. · 2017 · Evidence-based Complementary and Alternative Medicine · 98 citations
Dihydromyricetin is a flavonoid isolated from Ampelopsis grossedentata , which is traditionally used in China. Dihydromyricetin exhibits health‐benefiting activities with minimum adverse effects. D...
A reduction in reactive oxygen species contributes to dihydromyricetin-induced apoptosis in human hepatocellular carcinoma cells
Bin Liu, Xiaoyu Tan, Jian Liang et al. · 2014 · Scientific Reports · 89 citations
Reactive oxygen species (ROS) and cellular oxidant stress are considered inducers of carcinogenesis. However, the association of ROS with cancer is both complex and, at times, paradoxical. We asses...
Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury<i>via</i>JNK-dependent mechanism in mice
Jun Xie · 2015 · World Journal of Gastroenterology · 86 citations
These findings demonstrate that DHM alleviates CCl4-induced liver injury, suggesting that DHM is a promising candidate for reversing liver injury and ALF.
Mechanism of Dihydromyricetin on Inflammatory Diseases
Yang Sun, Shasha Liu, Songwei Yang et al. · 2022 · Frontiers in Pharmacology · 85 citations
Inflammation plays a crucial role in a variety of diseases, including diabetes, arthritis, asthma, Alzheimer’s disease (AD), acute cerebral stroke, cancer, hypertension, and myocardial ischemia. Th...
Reading Guide
Foundational Papers
Start with Shen et al. (2012, 209 citations) for alcohol-GABA_A basics and Liu et al. (2014, 89 citations) for ROS-hepatocyte links, as they establish core anti-intoxication and oxidative mechanisms.
Recent Advances
Study Xie (2015, 86 citations) for CCl4-JNK details and Wu et al. (2017, 78 citations) for diabetic extensions, capturing post-2015 injury model advances.
Core Methods
Core techniques include CCl4/alcohol mouse models (Xie, 2015), Hepa1-6 hepatocyte apoptosis assays (Liu et al., 2014), ROS quantification via DCFH-DA, and Western blots for Nrf2/JNK.
How PapersFlow Helps You Research Dihydromyricetin Hepatoprotective Mechanisms
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map 20+ papers from Shen et al. (2012, 209 citations) on alcohol intoxication to Xie (2015) on CCl4 injury, revealing Nrf2-JNK clusters. exaSearch uncovers hidden reviews like Arulselvan et al. (2016), while findSimilarPapers expands from Liu et al. (2014) ROS studies to hepatoprotective analogs.
Analyze & Verify
Analysis Agent employs readPaperContent on Xie (2015) to extract JNK mechanism details, then verifyResponse with CoVe chain-of-verification flags inconsistencies in ROS data from Liu et al. (2014). runPythonAnalysis performs statistical verification of dose-responses using pandas on extracted metrics, with GRADE grading scoring Shen et al. (2012) as high-evidence for GABA_A effects.
Synthesize & Write
Synthesis Agent detects gaps in human translation from animal models across Shen (2012) and Wu (2017), flagging Nrf2 contradictions. Writing Agent uses latexEditText and latexSyncCitations to draft mechanism reviews, latexCompile for figure-inclusive manuscripts, and exportMermaid to visualize Nrf2-ROS pathways from literature.
Use Cases
"Analyze dose-response curves for dihydromyricetin in CCl4 mouse liver injury models."
Research Agent → searchPapers('dihydromyricetin CCl4') → Analysis Agent → readPaperContent(Xie 2015) → runPythonAnalysis(pandas curve fitting, matplotlib plots) → outputs fitted EC50 values and statistical significance.
"Write a LaTeX review on DHM Nrf2 activation in alcohol hepatotoxicity."
Research Agent → citationGraph(Shen 2012) → Synthesis Agent → gap detection → Writing Agent → latexEditText(draft) → latexSyncCitations(20 papers) → latexCompile → outputs compiled PDF with pathway diagram.
"Find code for metabolomics analysis of DHM insulin sensitivity effects."
Research Agent → paperExtractUrls(Le 2016) → Code Discovery → paperFindGithubRepo → githubRepoInspect → outputs R scripts for flux analysis and Python adaptations for hepatocyte ROS modeling.
Automated Workflows
Deep Research workflow conducts systematic reviews of 50+ DHM papers, chaining searchPapers → citationGraph → GRADE grading to produce structured hepatoprotection reports. DeepScan applies 7-step analysis with CoVe checkpoints on Xie (2015) and Liu (2014) for mechanism verification. Theorizer generates hypotheses on Nrf2-GABA_A crosstalk from Shen (2012) and Liang (2014).
Frequently Asked Questions
What defines dihydromyricetin hepatoprotective mechanisms?
Dihydromyricetin protects liver via Nrf2 activation, ROS reduction, and JNK modulation against alcohol and CCl4 injury, as in Xie (2015) and Liu et al. (2014).
What methods study these mechanisms?
Researchers use mouse models for CCl4/alcohol injury (Xie, 2015; Shen et al., 2012), hepatocyte assays for ROS/apoptosis (Liu et al., 2014), and metabolomics for pathways (Le et al., 2016).
What are key papers?
Shen et al. (2012, 209 citations) on anti-intoxication; Xie (2015, 86 citations) on CCl4-JNK; Liu et al. (2014, 89 citations) on ROS in HCC.
What open problems exist?
Human trials lacking; unclear Nrf2 specificity vs. off-targets; translation from rodent models to clinical dosing unresolved.
Research Medicinal plant effects and applications with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Dihydromyricetin Hepatoprotective Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers